All

× UPDATE! Updated as of 24 May 2024.
Records 341 to 360 of 32645
 
Product Information
Registration Number
Generic Name
Brand Name
Dosage Strength
Dosage Form
Classification
Pharmacologic Category
Manufacturer
Country of Origin
Application Type
Issuance Date
Expiry Date
View BR-470 Live Attenuated Measles Vaccine None Multidose Freeze-Dried Powder For Injection (Multidose) (SC) Prescription Drug (RX) - Serum Institute of India Private Limited India - 08 March 2021 14 December 2025
View BR-471 Tetanus Toxoid ( Adsorbed ) None 40IU/0.5mL Suspension For Injection (IM) (Multidose) Prescription Drug (RX) - Serum Institue of India Private Limited India - 18 March 2022 30 August 2026
View BR-488 Human Albumin Zenalb-20 0.2 Solution For Injection (IV) Prescription Drug (RX) - Bio Products Laboratory Limited United Kingdom - 27 April 2022 03 March 2026
View BR-494 Human Albumin Albutein 20% 20% Solution for IV Infusion Prescription Drug (RX) - Grifols Biologicals LLC U.S.A. - 18 May 2021 25 April 2025
View BR-498 Inactivated Poliomyelitis Vaccine (Type 1,2 And 3) Imovax Polio Formulation: One dose (0.5 mL) contains: Poliovirus type 1, Mahoney strain (inactivated)-40 D-antigen Units Poliovirus type 2, MFF-I strain (inactivated)- 8 D-antigen Units Poliovirus type 3, Saukett strain (inactivated) - 32 D-antigen Units Suspension For Injection (IM/SC) Prescription Drug (RX) - Sanofi Pasteur France Renewal 05 May 2022 21 May 2027
View BR-500 Hepatitis B Vaccine (rdna) Hepliv 20mcg/mL Suspension for IM Injection Prescription Drug (Rx) Vaccine Bharat Biotech International Ltd. India Automatic Renewal 19 October 2021 09 October 2026
View BR-501 Hepatitis B Vaccine (rdna) Hepliv 20mcg/ mL Suspension for IM Injection Prescription Drug (Rx) Vaccine Bharat Biotech International Ltd. India Automatic Renewal 13 October 2021 09 October 2026
View BR-502 Hepatitis B Vaccine (rdna) Hepliv 100mcg/ 0.5mL Suspension for IM Injection Prescription Drug (Rx) Vaccine Bharat Biotech International Ltd. India Automatic Renewal 13 October 2021 09 October 2026
View BR-508 Diphtheria, Tetanus and Pertussis (acellular component), Hepatitis B (rDNA), Poliomyelitis (inactivated) and Haemophilus influenzae Type B Conjugate Vaccine (adsorbed) Infanrix Hexa Suspension for Injection (IM) (Preservative-free) Prescription Drug (RX) - GlaxoSmithKline Biologicals SA Belgium - 27 November 2020 11 February 2025
View BR-513 Hepatitis A Vaccine (Inactivated, Adsorbed) Avaxim 80 Formulation: Each dose (0.5 mL) contains: Hepatitis A virus, GBM Strain* (inactivated)** 80 ELISA units*** *Cultured on MRC-5 human diploid cells ** Adsorbed on hydrated aluminum hydroxide (0.15 mg of Al3) *** In the absence of an international standardised reference, the antigen content is expressed using an in-house reference Suspension for Injection (IM) Prescription Drug (RX) - Sanofi Pasteur France Renewal 30 January 2023 05 December 2027
View BR-514 Rabies Vaccine (Inactivated) (Wistar Strain Rabies) Verorab 2.5 IU/ 0.5 mL Powder for Suspension for Injection (ID/IM) Prescription Drug (RX) - Sanofi Pasteur SA France Renewal 03 July 2023 10 December 2027
View BR-515 Rabies Vaccine (Inactivated) Chirorab 2.5 I.U./mL Lyophilized Powder for Injection (ID/IM) Prescription Drug (RX) Vaccines Chiron Behring Vaccines Pvt., Ltd. India Renewal (Reconstruction) 27 February 2023 25 January 2026
View BR-518 Diphtheria, Tetanus, Pertussis (Acellular Component), And Poliomyelitis (Inactivated) Vaccine (Adsorbed) Tetraxim MULTICOMPONENT/0.5ML Suspension For Injection (IM) Prescription Drug (RX) - Sanofi Pasteur France Initial (Variation) 10 November 2022 10 November 2027
View BR-523 Diphtheria, Tetanus, Pertussis (Acellular Poliomyelitis (Inactivated) Vaccine and Haemophilus influenzae Type B Conjugate Vaccine (Adsorbed) Pentaxim After reconstitution, each dose (0.5 mL) contains: Diphtheria toxoid Tetanus toxoid Bordetella pertussis antigen Pertussis toxoid Filamentous hemagglutinin Poliovirus (Inactivated) >30 IU >40 IU Polysaccharide influenzae Type B Conjugated to tetanus protein of Haemophilus 10 mcg 18-30 mcg 25 mcg 25 mcg Type I poliomyelitis virus (inactivated) 40 D antigen units Type II poliomyelitis virus (inactivated) 8 D antigen units Type III poliomyelitis virus (inactivated) 32 D' antigen Suspension and Powder for Suspension for Injection (IM) Prescription Drug (RX) - Sanofi Pasteur, Inc. France Renewal 14 September 2023 21 August 2028
View BR-525 Tetanus Antitoxin Refined Antitet 1500 Iu 1500 IU 0.7mL Solution For Injection Prescription Drug (RX) Antisera Jiangxi Institute of Biological Products China Automatic Renewal 08 July 2023 09 June 2028
View BR-526 Tetanus Antitoxin Refined Antitet 5000 Iu 5000 IU/2mL Solution For Injection Prescription Drug (RX) Antisera Jiangxi Institute of Biological Products China Automatic Renewal 08 July 2023 09 June 2028
View BR-527 Tetanus Antitoxin Refined Antitet 3000 Iu 3000 I.U./0.95% Solution For Injection Prescription Drug (RX) Antisera Jiangxi Institute of Biological Products China Automatic Renewal 08 July 2023 19 June 2028
View BR-531 Human Albumin Albutein 0.05 Solution for Injection for Infusion (IV) Prescription Drug (RX) - Grifols Biologicals LLC U.S.A Renewal 28 April 2023 25 May 2027
View BR-536 Human Plasma Coagulation Factor VIII Emoclot 500 IU Lyophilized Powder for Injection (IV) Prescription Drug (RX) - Kedrion S.p.A Italy Initial (Variation) 06 October 2022 06 October 2027
View BR-539 Human Coagulation Factor IX Aimafix 500IU Lyophilized Powder For Injection Prescription Drug (RX) Plasma Fraction for Specific Use Kedrion S.P.A Italy Renewal 04 April 2019 14 January 2029